XTX Topco »

Monopar Therapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2026-06-30 $605k 6.5k 92.59

More positions owned by XTX Topco

Chevron Corporation (CVX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vaneck Etf Trust Semiconductr Etf (SMH)
Cme (CME)
Netflix (NFLX)
Cisco Systems (CSCO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Pepsi (PEP)
Intercontinental Exchange (ICE)
Boston Scientific Corporation (BSX)
ConocoPhillips (COP)
Meta Platforms Cl A (META)
Analog Devices (ADI)
Electronic Arts (EA)
Quanta Services (PWR)

View all positions for XTX Topco

Top funds holding Monopar Therapeutics

Henderson Group
Jupiter Topco
RA Capital Management
BlackRock
Deerfield Management Company
Saturn V Capital Management
Siren
ADAR1 Capital Management
Polar Capital Holdings
Vanguard Capital Management
Adage Capital Partners GP
TCG Crossover Management
Wellington Management Company
OrbiMed Advisors
Candriam Luxembourg S.C.A.

View all funds holding Monopar Therapeutics